C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2002
10/22/2002	US6469155 HIgR and related domain which binds glycoprotein D of herpes simplex virus
10/22/2002	US6469144 Apo-2li (apo-2 ligand inhibitor, related to apoptosis) monoclonal antibodies
10/22/2002	US6469143 Antigen/antibody specificity exchanger
10/22/2002	US6469142 Components of nmda receptors that have cation-selective channels and bind glutamate and nmda (n-methyl-d-aspartate)
10/22/2002	US6469140 Molecules of the card-related protein family and uses thereof
10/22/2002	US6468985 Administering nucleic acid molecule encoding retinoblastoma protein-interacting zinc finger protein at or adjacent to site of tumor, wherein protein comprises specified amino acid sequence and is expressed in tumor cell and reduces its growth
10/22/2002	US6468794 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
10/22/2002	US6468790 Metastatic breast and colon cancer regulated genes
10/22/2002	US6468776 Human serine protease
10/22/2002	US6468756 Methods of identifying compounds that bind to SNORF25 receptors
10/22/2002	US6468750 Cell regulation factor TTO 20
10/22/2002	US6468738 First polypeptide fused to a filamentous phage membrane cpviii anchor domain; mutating immunoglobulin variable domain-coding nucleotide sequence in the provided genome to form library of phage particles; immunoglobulin vh polypeptide (antibody heavy
10/22/2002	US6468547 Enhancement of tumor cell chemosensitivity and radiosensitivity using single chain secretory antibodies
10/22/2002	US6468538 Recombinant proteins for the fusion of the porcine reproductive and respiratory syndrome virus and its use in diagnosis
10/22/2002	US6468533 Polyclonal or monoclonal antibody that inhibits high mobility group 1 protein mediated activation of inflammatory cytokine cascade; sepsis
10/22/2002	US6468532 Methods of treating inflammatory diseases with anti-IL-8 antibody fragment-polymer conjugates
10/22/2002	US6468531 Method of promoting cellular function
10/22/2002	US6468530 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
10/22/2002	US6468529 Fab fragment of a monoclonal antibody; binds to c-met receptor; cancer treatment
10/22/2002	US6468528 Materials and methods to inhibit Hodgkin and Reed Sternberg cell growth
10/22/2002	US6468503 Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic precipitates in the cancer
10/22/2002	CA2216601C Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies
10/22/2002	CA2095335C Cell growth inhibitors
10/22/2002	CA2090126C Methods for the production of proteins with a desired function
10/20/2002	CA2382766A1 Novel bovine vdj cassette, bf1h1, suitable for antigenization
10/17/2002	WO2002082091A2 Method for identification of proteins from intracellular bacteria
10/17/2002	WO2002082089A2 Anti-idiotypic antibody and its use in diagnosis and therapy of hepatitis c virus related diseases
10/17/2002	WO2002082077A2 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
10/17/2002	WO2002082075A2 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
10/17/2002	WO2002082041A2 Production and use of novel peptide-based agents for use with bi-specific antibodies
10/17/2002	WO2002081754A1 Nucleic acid vaccines for prevention of flavivirus infection
10/17/2002	WO2002081747A1 Method of examining steroid responsiveness
10/17/2002	WO2002081703A2 Mitogenic oxygenase regulators
10/17/2002	WO2002081665A2 Implantation serine proteinases
10/17/2002	WO2002081661A2 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides
10/17/2002	WO2002081653A2 An animal model for enteric pathogens
10/17/2002	WO2002081649A2 ErbB INTERFACE PEPTIDOMIMETICS AND METHODS OF USE THEREOF
10/17/2002	WO2002081646A2 Epitope sequences
10/17/2002	WO2002081636A2 Protein modification and maintenance molecules
10/17/2002	WO2002081523A2 Method for preparing and selecting antibodies
10/17/2002	WO2002081522A1 Anti-osteopontin antibody and use thereof
10/17/2002	WO2002081513A2 Disease-associated protein
10/17/2002	WO2002081508A2 Use of cd25 binding molecules in steroid-resistant patients
10/17/2002	WO2002081504A2 Multimerization of hiv-1 vif protein as a therapeutic target
10/17/2002	WO2002081497A2 αξβ3 INTEGRIN-BINDING POLYPEPTIDE MONOBODIES AND THEIR USE
10/17/2002	WO2002081496A2 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
10/17/2002	WO2002080987A1 Anti-cd19 immunotoxins
10/17/2002	WO2002080986A1 Autoantibodies to glucose-6-phosphate isomerase and their participation in autoimmune disease
10/17/2002	WO2002080969A1 Remedies for infant chronic arthritis-relating diseases
10/17/2002	WO2002080968A1 Glycoprotein vi and uses thereof
10/17/2002	WO2002080967A1 Method to inhibit airway hyperresponsiveness using aerosolized t cell receptor antibodies
10/17/2002	WO2002080966A2 Method for producing a vaccine containing autologous antibodies
10/17/2002	WO2002080960A2 Treatment of neuropathologies associated with expression of tnf-alpha
10/17/2002	WO2002080891A1 Use of a tnf inhibitor for the treatment of low back pain
10/17/2002	WO2002080888A2 Estrogen receptor-related receptor alpha (err) agonist for inducing cartilage formation
10/17/2002	WO2002038607A3 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor
10/17/2002	WO2002036804A3 Method for detecting hematopoietic stem cells
10/17/2002	WO2002029061A3 G-protein coupled receptors
10/17/2002	WO2002023195A3 Method for detecting clostridium botulinum neurotoxin serotypes a, b, e and f in a sample
10/17/2002	WO2002015920A3 Treatment of hyperproliferative diseases
10/17/2002	WO2002008260A3 Bstp-ecg1 protein and related reagents and methods of use thereof
10/17/2002	WO2001098354A3 Human receptors
10/17/2002	WO2001098344A3 Angiogenesis-modulating compositions and uses
10/17/2002	WO2001098323A3 G-protein coupled receptors
10/17/2002	WO2001090151A3 Human receptor proteins; related reagents and methods
10/17/2002	WO2001058958A9 Antibody binding superficial zone protein and their uses in diagnosis and screening methods
10/17/2002	WO2001055170A9 Mob-5/hmob-5 as a cancer diagnostic marker
10/17/2002	WO2001054723A9 Therapeutic method for reducing angiogenesis
10/17/2002	WO2001049710A3 Method for identifying substances which mimic mammal epitopes
10/17/2002	WO2001042423A9 Compositions and methods for detecting stress-inducible proteins
10/17/2002	WO2001040497A3 Method for obtaining nucleic acids from an environment sample
10/17/2002	US20020152481 Genetic engineering; qualitative analysis
10/17/2002	US20020151706 Antiinflammatory agents
10/17/2002	US20020151698 For diagnosis, prevention, and treatment of cancer, and neurological and immune disorders
10/17/2002	US20020151695 Transforming growth factor-beta-related molecules and uses thereof
10/17/2002	US20020151688 Generating virally deactivated immunoglobulin; obtain mixture containing immunoglobulin, suspend in carbohydrate solution, reduce impurities, apply column, filter, recover efluent, inactivate with virus, preciptate and recover immunoglobulin
10/17/2002	US20020151682 Biological products
10/17/2002	US20020151677 Replikins and methods of identifying replikin-containing sequences
10/17/2002	US20020151517 Administering to the mammal nucleosomes(a complex of DNA and histones) that elicit the production of antinuclear autoantibodies sufficient to inhibit neoplastic cell growth
10/17/2002	US20020151514 Genes associated with mechanical stress, expression products therefrom, and uses thereof
10/17/2002	US20020151510 Methods and compositions for the treatment of human immunodeficiency virus infection
10/17/2002	US20020151500 Administering a therapeutically effective amount of a type-5 selective somatostatin agonist to patient
10/17/2002	US20020151498 Medicaments that modify activity of Lipolysis Stimulated Receptor and that can be used to influence partitioning of dietary lipids between liver and peripheral tissues, including adipose tissue
10/17/2002	US20020151494 Novel amino acid sequences for human semaphorin-like polypeptides
10/17/2002	US20020151485 Methods and compositions for modulating fertility
10/17/2002	US20020151484 SID nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof
10/17/2002	US20020151483 C3b/C4b complement receptor-like molecules and uses thereof
10/17/2002	US20020151476 An isolated and purified antiviral protein or peptide from Nostoc ellipsosporum; viricides; coupled to an effector molecule; inhibits replication of a virus, e.g. a retrovirus, in particular a human immunodeficiency virus, HIV
10/17/2002	US20020151464 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
10/17/2002	US20020151088 Rapamycin conjugates
10/17/2002	US20020151070 Lipid compounds and compositions containing them which can be used for the transfer of at least one active substance, in particular a polynucleotide, into a target cell and use in gene therapy
10/17/2002	US20020151061 Transform cells; obtain nutrient broth, incubate with binding polypeptide, transforming cells, evaluate cells for transformation activity
10/17/2002	US20020151056 Inducing cell differentiation in embryonic cells; obtain cells, inoculate nutrient broths, propagate cells, recover cells
10/17/2002	US20020151049 Self-enhancing, pharmacologically controllable expression systems
10/17/2002	US20020151024 DNA encoding mammalian phosphodiesterases
10/17/2002	US20020151022 Kinase capable of site-specific phosphorylation of IkappaBalpha
10/17/2002	US20020151021 Stimulus-inducible protein kinase complex and methods of use therefor
10/17/2002	US20020151015 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
10/17/2002	US20020151011 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
10/17/2002	US20020151009 Human polynucleotides, polypeptides, and antibodies

1 ... 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 ... 1494